Dr. Agarwal's Health Care Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2025
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Health Care Limited held its 15th AGM on September 24, 2025, via video conferencing from 3:00 pm to 3:45 pm, chaired by Dr. Amar Agarwal. All 10 resolutions on the agenda were passed with the requisite majority by the 43 members present. Key items approved include adoption of audited standalone and consolidated financial statements for FY2024-25, reappointment of Dr. Amar Agarwal and Dr. Adil Agarwal (CEO) who retire by rotation, appointment of Mr. Ankur Nand Thadani as a Non-executive Director, and ratification of the ESOP Scheme 2022 including its extension to subsidiary employees. The Chairman also noted that the Statutory Auditor and Secretarial Auditor reports contained no qualifications, observations, or adverse remarks. E-voting results will be shared with the stock exchanges within 2 working days.
This is a routine disclosure confirming that shareholders have approved all agenda items, including higher pay packages for the CEO and COO for FY2025-26 to FY2027-28 and the continuation of the ESOP scheme. No negative signals — clean audit reports, smooth AGM, and no contentious issues raised.